Innoviva, Inc.: Diferență între versiuni

1.357 de octeți adăugați ,  18 septembrie
Pagină nouă: Pagina dedicata companiei Innoviva, Inc. listata cu simbolul US.INVA ==Descriere companie== Innoviva, Inc. (https://www.inva.com/) is a company with a portfolio of royalties and other healthcare assets. Its royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including, RELVAR/BREO ELLIPTA (fluticasone furoate/ vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/ vilanterol, UMEC/VI) and TRELEGY ELLIPTA (the combination FF/UMEC/VI). Und...
(Pagină nouă: Pagina dedicata companiei Innoviva, Inc. listata cu simbolul US.INVA ==Descriere companie== Innoviva, Inc. (https://www.inva.com/) is a company with a portfolio of royalties and other healthcare assets. Its royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including, RELVAR/BREO ELLIPTA (fluticasone furoate/ vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/ vilanterol, UMEC/VI) and TRELEGY ELLIPTA (the combination FF/UMEC/VI). Und...)
(Nicio diferență)